To some, METR’s “time horizon plot” indicates that AI utopia—or apocalypse—is close at hand. The truth is more complicated.
As of April 2025, four CD19-directed chimeric antigen receptor (CAR)-T therapies and three CD20-targeting bispecific antibodies (BsAbs) have been US Food and Drug Administration (FDA) approved for the ...
Through its proprietary LTM, ‘NEXUS’, Fundamental reveals the hidden language of tables to unlock trillions of dollars in enterprise value, while a strategic partnership with AWS accelerates adoption ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results